GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Gross-Profit-to-Asset %
中文

Awakn Life Sciences (Awakn Life Sciences) Gross-Profit-to-Asset % : 11.40% (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Awakn Life Sciences's annualized Gross Profit for the quarter that ended in Oct. 2023 was $0.08 Mil. Awakn Life Sciences's average Total Assets over the quarter that ended in Oct. 2023 was $0.74 Mil. Therefore, Awakn Life Sciences's annualized Gross-Profit-to-Asset % for the quarter that ended in Oct. 2023 was 11.40%.


Awakn Life Sciences Gross-Profit-to-Asset % Historical Data

The historical data trend for Awakn Life Sciences's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Gross-Profit-to-Asset % Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23
Gross-Profit-to-Asset %
- -7.19 -26.58

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.61 -36.13 -38.83 3.82 11.40

Competitive Comparison of Awakn Life Sciences's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Awakn Life Sciences's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's Gross-Profit-to-Asset % falls into.



Awakn Life Sciences Gross-Profit-to-Asset % Calculation

Awakn Life Sciences's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jan. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Jan. 2023 )/( (Total Assets (A: Jan. 2022 )+Total Assets (A: Jan. 2023 ))/ count )
=-1.159/( (5.448+3.274)/ 2 )
=-1.159/4.361
=-26.58 %

Awakn Life Sciences's annualized Gross-Profit-to-Asset % for the quarter that ended in Oct. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Oct. 2023 )/( (Total Assets (Q: Jul. 2023 )+Total Assets (Q: Oct. 2023 ))/ count )
=0.084/( (0.678+0.796)/ 2 )
=0.084/0.737
=11.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Oct. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Awakn Life Sciences Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (Awakn Life Sciences) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines